Growth Metrics

Emergent BioSolutions (EBS) Amortization - Intangibles (2018 - 2025)

Historic Amortization - Intangibles for Emergent BioSolutions (EBS) over the last 8 years, with Q3 2025 value amounting to $16.3 million.

  • Emergent BioSolutions' Amortization - Intangibles changed 0.0% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year increase of 15.38%. This contributed to the annual value of $65.1 million for FY2024, which is 76.22% down from last year.
  • Per Emergent BioSolutions' latest filing, its Amortization - Intangibles stood at $16.3 million for Q3 2025, which was down 0.0% from $16.2 million recorded in Q2 2025.
  • Emergent BioSolutions' Amortization - Intangibles' 5-year high stood at $17.9 million during Q4 2022, with a 5-year trough of $14.0 million in Q4 2021.
  • Moreover, its 5-year median value for Amortization - Intangibles was $16.2 million (2023), whereas its average is $15.7 million.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first skyrocketed by 2785.71% in 2022, then plummeted by 949.72% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Amortization - Intangibles (Quarter) stood at $14.0 million in 2021, then increased by 27.86% to $17.9 million in 2022, then dropped by 9.5% to $16.2 million in 2023, then grew by 0.62% to $16.3 million in 2024, then changed by 0.0% to $16.3 million in 2025.
  • Its Amortization - Intangibles was $16.3 million in Q3 2025, compared to $16.2 million in Q2 2025 and $16.3 million in Q1 2025.